Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Deficit) - Schedule of Stock Options Activity (Details)

v3.20.4
Stockholders' Equity (Deficit) - Schedule of Stock Options Activity (Details) - $ / shares
 6 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Equity [Abstract]    
Number of Shares, Outstanding, Beginning balance 579,584 580,171
Number of Shares, Granted
Number of Shares, Exercised (10,750) (4,437)
Number of Shares, Forfeited and cancelled (7,463) (7,093)
Number of Shares, Outstanding, Ending balance 561,371 568,641
Number of Shares, Exercisable, Ending balance 493,224 377,428
Weighted Average Exercise Price, Outstanding, Beginning balance $ 11.00 $ 11.05
Weighted Average Exercise Price, Granted
Weighted Average Exercise Price, Exercised 4.60 4.69
Weighted Average Exercise Price, Forfeited and cancelled 7.31 12.32
Weighted Average Exercise Price, Outstanding, Ending balance 11.17 11.08
Weighted Average Exercise Price, Exercisable, Ending balance $ 10.94 $ 10.47
Weighted Average Remaining Contract Term (years), Outstanding, Beginning balance 7 years 6 months 18 days 8 years 7 months 2 days
Weighted Average Remaining Contract Term (years), Outstanding, Ending balance 6 years 10 months 14 days 8 years 26 days
Weighted Average Remaining Contract Term (years), Exercisable, Ending balance 6 years 8 months 2 days 7 years 8 months 16 days